Results 231 to 240 of about 38,595 (290)

Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods. [PDF]

open access: yesCardiovasc Diabetol
Morieri ML   +7 more
europepmc   +1 more source

Nutrition Strategies for Next‐Generation Incretin Therapies: A Systematic Scoping Review of the Current Evidence

open access: yesObesity Reviews, Volume 27, Issue 6, June 2026.
ABSTRACT Next‐generation incretin therapies, including semaglutide and tirzepatide, have transformed obesity and Type 2 diabetes management. However, evidence‐based nutritional strategies to support safe and effective use of these agents remain limited.
Marie Spreckley   +2 more
wiley   +1 more source

Publication Only

open access: yes
HemaSphere, Volume 10, Issue S1, June 2026.
wiley   +1 more source

Real-world effectiveness of adding newer generation GLP-1RA to SGLT2i in type 2 diabetes. [PDF]

open access: yesCardiovasc Diabetol
Chaiyakunapruk N   +5 more
europepmc   +1 more source

ISEV2026 Abstract Book

open access: yes
Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

GLP-1RA comparative effectiveness against dementia onset relative to other antidiabetic medications in a large, multi-site cohort of patients with type 2 diabetes. [PDF]

open access: yesAlzheimers Dement
Nance N   +14 more
europepmc   +1 more source

Depression following the initiation of glucagon‐like‐peptide‐1 receptor agonist therapy: A multinational self‐controlled case series study

open access: yes
Journal of Internal Medicine, Volume 299, Issue 6, Page 776-780, June 2026.
Vincent Ka Chun Yan   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy